Trials / Withdrawn
WithdrawnNCT03786536
Safety and Initial Performance of the MediSieve Magnetic Haemofiltration System
Clinical Investigation of the Safety and Initial Performance of the MediSieve Magnetic Haemofiltration System in Healthy Volunteers
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- MediSieve Limited · Industry
- Sex
- All
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
This is a single centre, prospective, non-randomised healthy volunteer study to be undertaken at University College Hospital London. The study will be used to demonstrate the safe use of the MediSieve blood filtration system in healthy volunteers prior to undertaking clinical trials on patients with relevant pathologies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MediSieve Magnetic Haemofiltration System | The MediSieve Magnetic Haemofiltration System is a medical device intended for use in extracorporeal clinical procedures to remove magnetic targets (e.g. malaria infected red blood cells) from a patient's bloodstream. |
Timeline
- Start date
- 2020-06-01
- Primary completion
- 2020-09-01
- Completion
- 2020-12-31
- First posted
- 2018-12-26
- Last updated
- 2023-11-18
Source: ClinicalTrials.gov record NCT03786536. Inclusion in this directory is not an endorsement.